Digestive & Intestinal Remedies (Pharmacies) - Papua New Guinea

Revenue in the Digestives & Intestinal Remedies market is projected to reach US$3.05m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 2.90%, resulting in a market volume of US$3.52m by 2029.
In global comparison, most revenue will be generated China (US$3.37bn in 2024).
In relation to total population figures, per person revenues of US$0.29 are generated in 2024.

Definition:
The Digestives and Intestinal Remedies market encompasses a range of over-the-counter (OTC) natural and synthetic digestive agents and remedies designed to address gastrointestinal concerns. These products are available through pharmacies and are provided in various forms such as pills, powder, capsules, liquids, solutions, suspensions, drops, and suppositories. The market excludes prescription medications, substances contravening state regulations, or items not explicitly categorized as digestive medications (e.g., pain relievers). Notable among the best-selling products in this category are Perenterol, Iberogast, Dulcolax, and Buscopan Plus. This market exclusively covers product sales through pharmacies.

Additional information:
The Digestives and Intestinal Remedies market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Digestive medicines
Remedies against gastrointestinal complaints

Prescription medicines
Homeopathic remedies
Tea

The Digestive & Intestinal Remedies (Pharmacies) market in Papua New Guinea is showing steady growth and development.

Customer preferences: Customers in Papua New Guinea have shown a growing preference for digestive and intestinal remedies in recent years. This can be attributed to several factors, including an increase in awareness about digestive health and the availability of a wider range of products in pharmacies. Customers are becoming more proactive about their health and are seeking remedies to address digestive issues such as indigestion, bloating, and constipation.

Trends in the market: One of the key trends in the Digestive & Intestinal Remedies market in Papua New Guinea is the growing demand for natural and herbal remedies. Customers are increasingly opting for products that are perceived to be more natural and have fewer side effects. This trend is in line with the global shift towards natural and holistic healthcare solutions. As a result, pharmacies in Papua New Guinea are stocking a wider range of herbal and natural remedies to cater to this demand. Another trend in the market is the increasing popularity of probiotics and digestive enzymes. Probiotics are live bacteria and yeasts that are beneficial for gut health, while digestive enzymes help in the breakdown and absorption of nutrients. These products have gained traction among customers who are looking for ways to improve their digestion and overall gut health. Pharmacies are responding to this trend by offering a variety of probiotic and digestive enzyme supplements.

Local special circumstances: Papua New Guinea is a country with a diverse population and a rich cultural heritage. Traditional medicine and remedies play an important role in the healthcare practices of many communities. This has influenced the demand for digestive and intestinal remedies in the country. Customers often seek remedies that are rooted in traditional healing practices, and pharmacies are catering to this demand by offering a range of traditional remedies alongside modern pharmaceutical products.

Underlying macroeconomic factors: The growing middle class in Papua New Guinea is a key driver of the Digestive & Intestinal Remedies market. As disposable incomes increase, customers have more purchasing power and are willing to spend on healthcare products. Additionally, the expanding healthcare infrastructure and improved access to healthcare services have contributed to the growth of the market. These factors have created a favorable environment for the development of the Digestive & Intestinal Remedies market in Papua New Guinea. In conclusion, the Digestive & Intestinal Remedies (Pharmacies) market in Papua New Guinea is experiencing steady growth due to increasing customer preferences for natural and herbal remedies, the popularity of probiotics and digestive enzymes, the influence of traditional medicine, and the underlying macroeconomic factors such as the growing middle class and improved access to healthcare services.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.